From: Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients
Independent predictor | Univariate regression | Multivariate regression | |||
---|---|---|---|---|---|
β | P | OR (95% CI) | P | AOR (95% CI) | |
S100A4 | 2.266 | 0.015* | 9.63 (1.56–59.3) | 0.041* | 8.4 (1.08–49.8) |
 Negative (r) |  |  |  |  |  |
 Positive |  |  |  |  |  |
Necrosis | 2.120 | 0.048* | 8.33 (1.08–75.6) | - | - |
 No (r) |  |  |  |  |  |
 Yes |  |  |  |  |  |
Size | −0.562 | 0.078 | 0.570 (0.3–1.06) | - | - |
AST | −0.047 | 0.056 | 0.95 (0.9–1.001) | - | - |
ALT | −0.097 | 0.05* | 0.91 (0.82–1) | 0.066 | 0.9 (0.8–1.01) |
 Constant | 0.771 | ||||
 Modelχ2 | 12.17, p = 0.002 | ||||
 % correctly predicted | 95.3% |